This is consistent with previously mentioned clinical data from MDC1A and Fukuyama muscular dystrophy patients showing significant upregulation of ECM genes indicative of active fibrosis at very early stages of disease (Taniguchi et al., 2006), supporting the hypothesis that fibrosis is at the center of CMD pathology. This evidence concerns the gene LAMA2 and congenital muscular dystrophy.